table of content
1 Introduction to Research & Analysis Reports
1.1 Recombinant Human Follicle-stimulating Hormone Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Human Follicle-stimulating Hormone Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Human Follicle-stimulating Hormone Overall Market Size
2.1 Global Recombinant Human Follicle-stimulating Hormone Market Size: 2022 VS 2030
2.2 Global Recombinant Human Follicle-stimulating Hormone Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Recombinant Human Follicle-stimulating Hormone Players in Global Market
3.2 Top Global Recombinant Human Follicle-stimulating Hormone Companies Ranked by Revenue
3.3 Global Recombinant Human Follicle-stimulating Hormone Revenue by Companies
3.4 Top 3 and Top 5 Recombinant Human Follicle-stimulating Hormone Companies in Global Market, by Revenue in 2022
3.5 Global Companies Recombinant Human Follicle-stimulating Hormone Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant Human Follicle-stimulating Hormone Players in Global Market
3.6.1 List of Global Tier 1 Recombinant Human Follicle-stimulating Hormone Companies
3.6.2 List of Global Tier 2 and Tier 3 Recombinant Human Follicle-stimulating Hormone Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Recombinant Human Follicle-stimulating Hormone Market Size Markets, 2022 & 2030
4.1.2 75IU
4.1.3 150IU
4.1.4 Others
4.2 By Type - Global Recombinant Human Follicle-stimulating Hormone Revenue & Forecasts
4.2.1 By Type - Global Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2023
4.2.2 By Type - Global Recombinant Human Follicle-stimulating Hormone Revenue, 2023-2030
4.2.3 By Type - Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Human Follicle-stimulating Hormone Market Size, 2022 & 2030
5.1.2 Infertility Treatment
5.1.3 Assisted Reproductive Technology
5.2 By Application - Global Recombinant Human Follicle-stimulating Hormone Revenue & Forecasts
5.2.1 By Application - Global Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2023
5.2.2 By Application - Global Recombinant Human Follicle-stimulating Hormone Revenue, 2023-2030
5.2.3 By Application - Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Recombinant Human Follicle-stimulating Hormone Market Size, 2022 & 2030
6.2 By Region - Global Recombinant Human Follicle-stimulating Hormone Revenue & Forecasts
6.2.1 By Region - Global Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2023
6.2.2 By Region - Global Recombinant Human Follicle-stimulating Hormone Revenue, 2023-2030
6.2.3 By Region - Global Recombinant Human Follicle-stimulating Hormone Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2030
6.3.2 US Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.3.3 Canada Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.3.4 Mexico Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2030
6.4.2 Germany Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.4.3 France Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.4.4 U.K. Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.4.5 Italy Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.4.6 Russia Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.4.7 Nordic Countries Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.4.8 Benelux Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2030
6.5.2 China Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.5.3 Japan Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.5.4 South Korea Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.5.5 Southeast Asia Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.5.6 India Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2030
6.6.2 Brazil Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.6.3 Argentina Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Recombinant Human Follicle-stimulating Hormone Revenue, 2018-2030
6.7.2 Turkey Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.7.3 Israel Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.7.4 Saudi Arabia Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
6.7.5 UAE Recombinant Human Follicle-stimulating Hormone Market Size, 2018-2030
7 Players Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.1.4 Merck Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.1.5 Merck Key News
7.2 Ferring
7.2.1 Ferring Corporate Summary
7.2.2 Ferring Business Overview
7.2.3 Ferring Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.2.4 Ferring Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.2.5 Ferring Key News
7.3 Livzon
7.3.1 Livzon Corporate Summary
7.3.2 Livzon Business Overview
7.3.3 Livzon Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.3.4 Livzon Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.3.5 Livzon Key News
7.4 Gedeon Richter
7.4.1 Gedeon Richter Corporate Summary
7.4.2 Gedeon Richter Business Overview
7.4.3 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.4.4 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.4.5 Gedeon Richter Key News
7.5 GenSci
7.5.1 GenSci Corporate Summary
7.5.2 GenSci Business Overview
7.5.3 GenSci Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.5.4 GenSci Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.5.5 GenSci Key News
7.6 Teva
7.6.1 Teva Corporate Summary
7.6.2 Teva Business Overview
7.6.3 Teva Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.6.4 Teva Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.6.5 Teva Key News
7.7 ChangChun High & New Technology
7.7.1 ChangChun High & New Technology Corporate Summary
7.7.2 ChangChun High & New Technology Business Overview
7.7.3 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.7.4 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.7.5 ChangChun High & New Technology Key News
7.8 ABL
7.8.1 ABL Corporate Summary
7.8.2 ABL Business Overview
7.8.3 ABL Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.8.4 ABL Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.8.5 ABL Key News
7.9 Scripps Laboratories
7.9.1 Scripps Laboratories Corporate Summary
7.9.2 Scripps Laboratories Business Overview
7.9.3 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.9.4 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.9.5 Scripps Laboratories Key News
7.10 Alphamab Oncology
7.10.1 Alphamab Oncology Corporate Summary
7.10.2 Alphamab Oncology Business Overview
7.10.3 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.10.4 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.10.5 Alphamab Oncology Key News
7.11 Hunan Jingfeng Pharmaceutical
7.11.1 Hunan Jingfeng Pharmaceutical Corporate Summary
7.11.2 Hunan Jingfeng Pharmaceutical Business Overview
7.11.3 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.11.4 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.11.5 Hunan Jingfeng Pharmaceutical Key News
7.12 Qilu Pharmaceutical
7.12.1 Qilu Pharmaceutical Corporate Summary
7.12.2 Qilu Pharmaceutical Business Overview
7.12.3 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.12.4 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.12.5 Qilu Pharmaceutical Key News
7.13 Beijing SL Pharmaceutical
7.13.1 Beijing SL Pharmaceutical Corporate Summary
7.13.2 Beijing SL Pharmaceutical Business Overview
7.13.3 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Major Product Offerings
7.13.4 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue in Global Market (2018-2023)
7.13.5 Beijing SL Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
